Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

American Beacon ARK Transformational Innovation Fund Y Class (ADNYX)

Net Asset Value
1 Day
Overall Morningstar Rating
Style or Category
No Load
Sales Expenses
Expense Ratio
Morningstar Risk Rating™
Investment Objective The investment seeks long-term growth of capital. Under normal circumstances, substantially all of the fund's assets will be invested in a portfolio of equity securities including common stocks and other equity investments or ownership interests in business enterprises that are relevant to the fund's investment theme of disruptive innovation. It may invest indirectly in bitcoins through a Delaware statutory trust, which issues shares that are registered with the Securities and Exchange Commission under the Securities Act of 1933. Bitcoins are a digital commodity that is not issued by a government, bank or central organization. The fund is non-diversified.


1 month+1.34% 3 years--
3 months+14.94% 5 years--
1 year-- Since inception+49.40%
Data through --

Peer Comparisonvs. Technology

Performance 5-yr return--+17.88%
Expense ratio2.60%1.42%
Risk 5 year sharpe ratio--1.24
Net assets$7.4M$1.2B
Average market cap$11.5B$65.3B
Average P/E--28.6
Portfolio turnover----

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyAmerican Beacon
Fund manager & tenureCatherine Wood / 0 Years
Minimal initial investment$100,000.00
Minimum IRA investment--


U.S. stock69.34%
International stock11.17%
Fixed income9.02%
Top 5 Sectors
Portfolio weighting
Business service --
Consumer goods --
Consumer service --
Energy --
Financial service --
Top 10 Holdings
Portfolio weighting
GBTC Bitcoin Investment Trust9.02%
TSLA Tesla5.46%
AMZN Amazon4.30%
ATHN athenahealth Inc3.55%
TWTR Twitter3.49%
SSYS Stratasys Ltd3.47%
ILMN Illumina Inc3.34%
JUNO Juno Therapeutics Inc3.19%
BLUE bluebird bio Inc2.46%